share_log

Castle Biosciences Sees FY Revenue $255M-$330M

Benzinga Real-time News ·  Sep 20, 2022 16:16
Castle Biosciences Sees FY Revenue $255M-$330M
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment